Dr Lal Pathlabs
₹1,859.9-25.20 (-1.34%)as of 2026-10-16
- Market Cap
- ₹31,170Cr.
- P/E Ratio
- 55.4
- P/B Ratio
- 12.40
- EPS (TTM)
- ₹33.57
- Day Range
- ₹1,851.9 – ₹1,907.9
- Div Yield
- 0.73%
- ROCE
- 28%
- ROE
- 22.3%
52W Low: ₹1,27352W High: ₹2,039
Themes:🏥 Healthcare & Hospitals
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 11.0% a year over three years.
- Debt is 0.08× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Dr_Lal_Pathlabs — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 55.4P/E: 55.4 | P/B: 12.40Growth
GrowingSales CAGR — 3Y: 11% · 1Y: 14%Profitability
High MarginROCE: 28% | ROE: 22.3%Key Metrics
Valuation
PEG Ratio 1.85
Price / Sales 10.78x
Price / FCF 67.3x
Book Value ₹150
Margins & returns
Operating Margin 29%
Net Margin 18.9%
Return on Assets 17.4%